142.60
  Price0.37%   +0.52
(After Hours: 142.35 -0.25 -0.18%)
Aug-11-22 03:11AM This Nasal Spray For Eye Disease Stock Is 'Attractive', Has Potential 160% UpsideBenzinga
Aug-10-22 04:37AM 10 defensive stocks that can also provide you with growth and dividends over the long termMarketWatch
10:05AM 10 defensive stocks that can also provide you with growth and dividends over the long termMarketWatch
Aug-09-22 11:56AM Reata (RETA) Q2 Earnings Miss, Revenues Down Y/Y, Stock DownZacks Investment Research
Aug-08-22 12:35PM Vanguard High Dividend Yield ETF: The Best Offense Is DefenseSeeking Alpha
Aug-07-22 09:00AM 3 Unstoppable Stocks That Don't Care About the Bear MarketThe Motley Fool
01:25AM Teva Pharmaceutical: A Gem Among Generic Pharmaceutical CompaniesSeeking Alpha
Aug-06-22 06:08AM 3 Unstoppable Dividend Stocks to Buy in AugustThe Motley Fool
Aug-05-22 11:45AM Ironwood (IRWD) Q2 Earnings Miss, Keeps 2022 Sales GuidanceZacks Investment Research
10:00AM 3 Reasons Why AbbVie Stock Could Be Approaching a Make or Break MomentThe Motley Fool
Aug-05-22 09:00AM Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to KnowZacks Investment Research
Aug-03-22 10:15AM 1 Reason to Buy Pfizer Stock After Earnings, and 1 Reason to SellThe Motley Fool
08:32AM Famed "Big Short" Investor Loves This Multibillion-Dollar Company -- Should You?The Motley Fool
Aug-03-22 06:20AM Is Invesco Dynamic Pharmaceuticals ETF (PJP) a Strong ETF Right Now?Zacks Investment Research
05:52AM Medicare Drug Pricing Changes Could Be Coming: Time to Ditch Pharma Stocks?The Motley Fool
Jun-07-22 11:45AM Warren Buffett Just Sold This Popular Stock -- Should You?The Motley Fool
11:00AM Here's What This Drug News Could Mean for AbbVie's ShareholdersThe Motley Fool
Jun-06-22 05:45AM AbbVie (ABBV) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research
Jun-05-22 02:29AM How do we test for monkeypox?Quartz
07:04AM 3 Great Dividend Stocks to Buy in JuneThe Motley Fool
Jun-05-22 05:43AM Can the Best-Selling Drugs of 2021 Repeat Their Performance?The Motley Fool
Jun-04-22 11:23AM 2 Top Dividend Kings to Buy for the Long HaulThe Motley Fool
Jun-03-22 11:45AM 3 Reasons to Buy This Blue-Chip StockThe Motley Fool
09:00AM AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research
Jun-01-22 02:23AM ‘I needed something to do’: How working in retirement is being embraced by older adults and companiesMarketWatch
11:15AM 1 Green Flag for AbbVie in 2022 and 1 Red FlagThe Motley Fool
Jun-01-22 05:52AM My 3 Favorite Dividend Stocks to Buy in JuneThe Motley Fool
May-29-22 08:58AM A new generation of ulcerative colitis drugs is in development. Will they be blockbusters for Lilly and Pfizer?MarketWatch
07:31AM 3 Dividend Stocks You Can Buy and Hold ForeverThe Motley Fool
May-28-22 11:50AM A new generation of ulcerative colitis drugs is in development. Will they be blockbusters for Lilly and Pfizer?MarketWatch
06:53AM Wall Street Breakfast: What Moved MarketsSeeking Alpha
May-27-22 07:24AM A new generation of ulcerative colitis drugs is in development. Will they be blockbusters for Lilly and Pfizer?MarketWatch
May-26-22 02:40AM A new generation of ulcerative colitis drugs is in development. Will they be the blockbusters that pharma wants?MarketWatch
07:51AM Amgen (AMGN) Ahead of Industry This Year So Far: What's Next?Zacks Investment Research
May-26-22 06:00AM 3 Healthcare Stocks You Can Buy and Hold for the Next DecadeThe Motley Fool
05:57AM Why Did Warren Buffett Just Sell 1 of His Best Stocks of 2022?The Motley Fool
May-25-22 12:05PM SpringWorks (SWTX) Down Despite Desmoid Tumors Study Meeting GoalZacks Investment Research
11:00AM 2 Dividend Kings That Are Soundly Beating the Market in 2022The Motley Fool
May-25-22 05:38AM 3 Recession-Proof Stocks To Protect Your Portfolio From Fed-Induced TurmoilInvesting.com
May-24-22 01:02AM Why High Dividend ETFs are Beating the MarketZacks Investment Research
12:04PM 3 Great Dividend Stocks to Buy Now and HoldZacks Investment Research
May-24-22 10:00AM These 2 Numbers Could Spell Trouble for AbbVie StockThe Motley Fool
08:08AM PepsiCo Becomes a Dividend KingThe Motley Fool
May-23-22 11:46AM AbbVie (ABBV) Files NDA for Parkinson's Disease CandidateZacks Investment Research
10:33AM Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022Benzinga
May-23-22 09:05AM What 8 Analyst Ratings Have To Say About AbbVieBenzinga
May-21-22 01:18AM ‘I needed something to do’: How working in retirement is being embraced by older adults and companiesMarketWatch
May-20-22 09:00AM Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to KnowZacks Investment Research
08:50AM Pharma Stock Roundup: FDA Nod to PFE COVID Jab for Age 5-11 & LLY's TirzepatideZacks Investment Research
May-19-22 06:40AM These 3 Stocks Have Doubled Over the Past 3 Years. Can They Do It Again?The Motley Fool
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune diseases; IMBRUVICA, an oral therapy for treating chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, to treat adults with genotype 1 chronic hepatitis C. It also provides Kaletra, an anti- human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent RSV infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males diagnosed with symptomatic low testosterone; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid for hypothyroidism; and Lupron, a product for the palliative treatment of prostate cancer, endometriosis, and central precocious puberty, as well as for the treatment of patients with anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Sevoflurane, an anesthesia product for human use; and ZINBRYTA, a treatment for relapsing forms of multiple sclerosis. It serves wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. AbbVie Inc. has collaboration with Alector, Inc.; C2N Diagnostics; Voyager Therapeutics, Inc.; Janssen Biotech, Inc.; International Myeloma Foundation; Calibr and Scripps Research; The Institute for Research in Immunology and Cancer – Commercialization of Research; the Université de Montréal; Tolero Pharmaceuticals, Inc.; Galapagos; Mission Therapeutics Ltd; and Bristol-Myers Squibb Company. The company was incorporated in 2012 and is based in North Chicago, Illinois.
Cap:    |  Volume (24h):